The company will develop the first orthopedic devices designed to reduce biofilm formation after implantation. The Semprus technology system creates a highly non-fouling performance that reduces the attachment of protein, cells, bacteria and other biological matter on medical device surfaces.
Related Articles on Orthopedic Devices:
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
K2M Launches Two Lateral Spine Surgery Systems Globally
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.